Peripheral Arterial Disease
Guidelines on peripheral arterial disease by the European Society of Cardiology
Smoking cessation is recommended in all patients with peripheral arterial disease (PAD).
Healthy diet and physical activity are recommended for all patients with PAD.
Statins are recommended in all patients with PAD.
In patients with PAD, it is recommended to reduce LDL-C to <1.8 mmol/L (70 mg/dL) or decrease it by ≥50% if baseline values are 1.8–3.5 mmol/L (70–135 mg/dL).
In diabetic patients with PAD, strict glycemic control is recommended.
Antiplatelet therapy is recommended in patients with symptomatic PAD.
In patients with PAD and hypertension, it is recommended to control blood pressure at <140/90 mm Hg.
Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs) should be considered as first-line therapy in patients with PAD and hypertension.
For further reading, see Peripheral Arterial Occlusive Disease
Medscape © 2017 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: John Anello, Brian Feinberg, John Heinegg, et. al. New Clinical Practice Guidelines, September 2017 - Medscape - Sep 15, 2017.